Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-05

Clinical Trial Update: Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia [Phase 4]

View source ↗

Summary

Phase 4 trial updates completion of a non-inferiority study comparing aliskiren to losartan for hypertension with hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cozaar (losartan)
  • Tekturna (aliskiren)

Snippet

Sponsor: Hansung University | Conditions: Hypertension,Essential, Hyperuricemia | Phase 4 | Status: COMPLETED